Eastman Chemical Company EMN R3K
Company Overview
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids. It serves transportation, personal care, wellness, food, feed, agriculture, building and construction, water treatment, energy, consumables, durables, and electronics markets. Its Advanced Materials segment provides copolyesters, cellulosic biopolymers, polyvinyl butyral sheets, polyester films and window and protective films for value-added end uses in the transportation, durables, electronics, building and construction, medical and pharma, and consumables end-markets. The company's Chemical Intermediates segment offers olefin and acetyl derivatives, methylamines and salts, higher amines and solvents, ethylene, and commodity solvents; and primary non-phthalate and phthalate plasticizers, and niche non-phthalate plasticizers for industrial chemicals and processing, building and construction, health and wellness, and food and feed. Its Fibers segment provides cellulose acetate tow, triacetin, cellulose acetate flake, acetic acid, and acetic anhydride for use in filtration media primarily cigarette filters; natural and solution dyed acetate yarns, and staple fiber for use in consumables, and health and wellness markets; and wet-laid nonwoven media, specialty and engineered papers, and cellulose acetate fibers for transportation, industrial, agriculture and mining, and aerospace markets. Eastman Chemical Company was founded in 1920 and is headquartered in Kingsport, Tennessee.
Why Investors Should Care
Trades at a P/E of 18.3, below the sector median of 22.2.
Offers a dividend yield of 4.77%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $8.75B (-6.7% YoY); net profit $474.00M.
- Trailing 12 Months Year-on-year growth — revenue +9.9%, earnings +32.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 2.3%, profit CAGR 1.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 2.31% |
| 1 Year: | 9.90% |
Compounded Profit Growth
| 5 Years: | 1.87% |
| 1 Year: | 32.50% |
Stock Price Performance
| 1 Year: | +11.04% |
| 6 Months: | +3.51% |
| 3 Months: | -0.68% |
| 1 Month: | -4.41% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)44.13 · Neutral
P/E of 18.33 is below the sector median of 22.16 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Attractive dividend yield of 4.77%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | EMN Eastman Chemical Company R3K | 70.39 | 18.33 | $8.05B | 4.77% | 12.55% | 7.33% | 2.31% | 1.87% |
| 2 | LIN Linde plc NDXSPXR3K | 468.38 | 30.22 | $215.91B | 1.40% | 12.46% | 18.40% | 13.90% | 18.47% |
| 3 | SCCO Southern Copper Corporation R3K | 208.56 | 31.27 | $176.10B | 2.24% | 36.40% | 49.90% | 8.32% | 3.80% |
| 4 | NEM Newmont Corporation SPXR3K | 127.09 | 16.01 | $133.91B | 0.84% | - | 25.91% | 6.53% | 20.15% |
| 5 | RIO Rio Tinto Group | 103.83 | 14.07 | $130.27B | 4.78% | 13.65% | 19.31% | 1.24% | -7.00% |
| 6 | FCX Freeport-McMoRan Inc. SPXR3K | 76.62 | 37.56 | $110.03B | 0.78% | 12.50% | 14.75% | 1.35% | -1.26% |
| 7 | AEM Agnico Eagle Mines Limited | 201.84 | 17.27 | $102.20B | 0.88% | 19.78% | 22.97% | 27.53% | 88.11% |
| 8 | SHW The Sherwin-Williams Company SPXR3K | 326.09 | 30.05 | $79.16B | 1.00% | 21.93% | 65.12% | 6.18% | 8.26% |
| 9 | ECL Ecolab Inc. SPXR3K | 278.11 | 37.33 | $77.96B | 1.05% | 15.10% | 21.96% | 6.55% | 9.74% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.45B | - | 2.24B | 2.30B | 2.29B | - | 2.30B | 2.42B | 2.46B | 2.36B | 2.61B | 2.62B | 2.55B | 2.38B | 2.38B | 2.36B | 2.33B | 2.21B | 2.24B | 1.92B | 2.12B | 2.19B | 2.41B | 2.65B | 2.72B | 2.69B | 2.71B | 2.78B | 2.71B | 2.41B | 2.32B | 2.27B | 2.31B | 2.36B | 2.46B | 2.29B | 2.29B | 2.20B | 2.18B | 2.51B |
| Gross Profit | 695.00M | 509.00M | 634.00M | 605.00M | 621.00M | 490.00M | 605.00M | 630.00M | 671.00M | 457.00M | 581.00M | 704.00M | 728.00M | 466.00M | 574.00M | 589.00M | 574.00M | 497.00M | 577.00M | 371.00M | 501.00M | 526.00M | 598.00M | 681.00M | 662.00M | 559.00M | 550.00M | 670.00M | 541.00M | 529.00M | 584.00M | 484.00M | 532.00M | 599.00M | 605.00M | 567.00M | 506.00M | 433.00M | 431.00M | 560.00M |
| Operating Income | 432.00M | - | 399.00M | 376.00M | 356.00M | - | 397.00M | 420.00M | 460.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | 256.00M | 124.00M | 251.00M | 255.00M | 232.00M | 116.00M | 278.00M | 292.00M | 323.00M | 491.00M | 290.00M | 344.00M | 412.00M | 34.00M | 209.00M | 258.00M | 266.00M | 26.00M | 258.00M | 27.00M | 161.00M | 32.00M | 274.00M | -146.00M | 351.00M | 378.00M | 235.00M | 256.00M | 301.00M | 134.00M | 272.00M | 178.00M | 165.00M | 230.00M | 180.00M | 182.00M | 140.00M | 47.00M | 107.00M | 183.00M |
| Diluted EPS | 1.71 | 0.83 | 1.69 | 1.71 | 1.56 | 0.79 | 1.89 | 2.00 | 2.22 | 3.39 | 2.00 | 2.39 | 2.89 | 0.24 | 1.49 | 1.85 | 1.93 | 0.19 | 1.89 | 0.20 | 1.18 | 0.23 | 1.99 | -1.07 | 2.57 | 2.81 | 1.80 | 2.03 | 2.46 | 1.12 | 2.27 | 1.49 | 1.39 | 1.94 | 1.53 | 1.57 | 1.20 | 0.40 | 0.93 | 1.59 |
| R&D Expense | 59.00M | - | 54.00M | 55.00M | 54.00M | - | 57.00M | 58.00M | 59.00M | - | 56.00M | 60.00M | 60.00M | - | 58.00M | 57.00M | 59.00M | - | 61.00M | 52.00M | 56.00M | - | 58.00M | 63.00M | 66.00M | - | 65.00M | 67.00M | 68.00M | 62.00M | 60.00M | 60.00M | 59.00M | 60.00M | 65.00M | 67.00M | 67.00M | 63.00M | 60.00M | 65.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.94B | 4.40B | 5.84B | 7.18B | 8.10B | 9.35B | 9.53B | 9.65B | 9.01B | 9.55B | 10.15B | 9.27B | 8.47B | 10.48B | 10.58B | 9.21B | 9.38B | 8.75B |
| Gross Profit | 1.08B | 1.03B | 1.46B | 1.57B | 1.76B | 2.78B | 2.22B | 2.58B | 2.36B | 2.36B | 2.48B | 2.23B | 1.98B | 2.50B | 2.14B | 2.06B | 2.29B | 1.84B |
| Operating Income | 551.00M | 345.00M | 844.00M | 937.00M | 800.00M | 1.86B | 1.16B | 1.38B | 1.38B | 1.53B | - | - | - | - | - | - | - | - |
| Net Income | 346.00M | 136.00M | 425.00M | 646.00M | 437.00M | 1.17B | 751.00M | 848.00M | 854.00M | 1.38B | 1.08B | 759.00M | 478.00M | 857.00M | 793.00M | 894.00M | 905.00M | 474.00M |
| Diluted EPS | 4.55 | 0.93 | 2.88 | 4.52 | 2.93 | 7.44 | 4.97 | 5.66 | 5.75 | 9.47 | 7.56 | 5.48 | 3.50 | 6.25 | 6.35 | 7.49 | 7.67 | 4.10 |
| R&D Expense | 143.00M | 124.00M | 152.00M | 159.00M | 198.00M | 193.00M | 227.00M | 242.00M | 223.00M | 227.00M | 235.00M | 234.00M | 226.00M | 254.00M | 264.00M | 239.00M | 250.00M | 255.00M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 5.51B | 5.99B | 6.18B | 11.71B | 11.85B | 16.07B | 15.58B | 15.46B | 16.00B | 15.99B | 16.01B | 16.08B | 15.52B | 14.67B | 14.63B | 15.21B | 14.86B |
| Total Equity | 2.08B | 1.55B | 1.51B | 1.63B | 1.87B | 2.94B | 3.80B | 3.51B | 3.94B | 4.53B | 5.40B | 5.80B | 5.96B | 6.02B | 5.70B | 5.15B | 5.46B | 5.78B | 5.96B |
| Cash & Equivalents | 888.00M | 387.00M | 793.00M | 516.00M | 577.00M | 249.00M | 237.00M | 214.00M | 293.00M | 181.00M | 191.00M | 226.00M | 204.00M | 564.00M | 459.00M | 493.00M | 548.00M | 837.00M | 566.00M |
| Long Term Debt | - | - | 1.60B | 1.60B | 1.45B | 4.78B | 4.25B | 7.25B | 6.58B | 6.31B | 6.15B | 5.92B | 5.61B | 5.27B | 4.41B | 4.03B | 4.30B | 4.57B | 4.20B |
| Total Liabilities | - | - | 4.00B | 4.36B | 4.28B | 8.68B | 7.97B | 12.48B | 11.56B | 10.85B | 10.52B | 10.12B | 9.98B | 9.97B | 9.73B | 9.43B | 9.10B | 9.36B | 8.82B |
| Current Liabilities | - | - | 800.00M | 1.07B | 1.11B | 1.36B | 1.47B | 2.02B | 2.06B | 1.79B | 1.98B | 1.85B | 1.79B | 2.04B | 2.97B | 3.25B | 2.58B | 2.71B | 2.65B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 653.00M | 758.00M | 575.00M | 625.00M | 1.13B | 1.30B | 1.43B | 1.62B | 1.39B | 1.66B | 1.54B | 1.50B | 1.46B | 1.62B | 975.00M | 1.37B | 1.29B | 970.00M |
| Investing Cash Flow | -376.00M | -369.00M | -442.00M | -142.00M | -2.96B | -457.00M | -4.09B | -693.00M | -655.00M | -643.00M | -463.00M | -480.00M | -394.00M | -29.00M | 392.00M | -432.00M | -534.00M | -462.00M |
| Financing Cash Flow | -779.00M | 18.00M | -411.00M | -423.00M | 1.50B | -859.00M | 2.64B | -844.00M | -838.00M | -1.01B | -1.04B | -1.04B | -704.00M | -1.69B | -1.32B | -888.00M | -454.00M | -797.00M |
| Capital Expenditure | -634.00M | -310.00M | -243.00M | -457.00M | -465.00M | -483.00M | -593.00M | -652.00M | -626.00M | -649.00M | -528.00M | -425.00M | -383.00M | -555.00M | -611.00M | -828.00M | -599.00M | -546.00M |
| Free Cash Flow | 19.00M | 448.00M | 332.00M | 168.00M | 663.00M | 814.00M | 840.00M | 972.00M | 759.00M | 1.01B | 1.01B | 1.08B | 1.07B | 1.06B | 364.00M | 546.00M | 688.00M | 424.00M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | - | - | - | 900.00M | - | - | - | - |
| Dividends Paid | 135.00M | 128.00M | 127.00M | 136.00M | 192.00M | 140.00M | 210.00M | 238.00M | 272.00M | 296.00M | 318.00M | 343.00M | 358.00M | 375.00M | 381.00M | 376.00M | 379.00M | 381.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 18.3% | 23.5% | 25.0% | 21.9% | 21.7% | 29.7% | 23.3% | 26.7% | 26.2% | 24.7% | 24.4% | 24.1% | 23.3% | 23.9% | 20.2% | 22.4% | 24.4% | 21.1% |
| Operating Margin % | 9.3% | 7.8% | 14.4% | 13.1% | 9.9% | 19.9% | 12.2% | 14.3% | 15.4% | 16.0% | - | - | - | - | - | - | - | - |
| Net Margin % | 5.8% | 3.1% | 7.3% | 9.0% | 5.4% | 12.5% | 7.9% | 8.8% | 9.5% | 14.5% | 10.6% | 8.2% | 5.6% | 8.2% | 7.5% | 9.7% | 9.6% | 5.4% |
| ROE % | 22.3% | 9.0% | 26.1% | 34.5% | 14.8% | 30.7% | 21.4% | 21.5% | 18.8% | 25.6% | 18.6% | 12.7% | 7.9% | 15.0% | 15.4% | 16.4% | 15.7% | 8.0% |
| ROCE % | - | 7.3% | 17.2% | 18.5% | 7.7% | 17.9% | 8.3% | 10.2% | 10.1% | 10.9% | - | - | - | - | - | - | - | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 14.81% | 16.94M | $1.11B |
| 2 | Vanguard Portfolio Management LLC | 6.60% | 7.55M | $496.22M |
| 3 | Dimensional Fund Advisors LP | 4.51% | 5.16M | $339.20M |
| 4 | Vanguard Capital Management LLC | 4.51% | 5.16M | $338.97M |
| 5 | State Street Corporation | 3.65% | 4.17M | $273.87M |
| 6 | Morgan Stanley | 2.91% | 3.33M | $218.80M |
| 7 | Franklin Resources, Inc. | 2.51% | 2.87M | $188.69M |
| 8 | Massachusetts Financial Services Co. | 2.33% | 2.66M | $175.01M |
| 9 | Bank of America Corporation | 2.16% | 2.47M | $162.25M |
| 10 | Earnest Partners LLC | 2.10% | 2.40M | $157.84M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for EMN
(EMN) Risk Channels and Responsive Allocation - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQVU1TEZER1FoMzBBb2pPbXB1U1liMXRMdWItOXZJM2EydWpldEVpRmRMWlVWU3h6RXczZ0ViSng2RDNOR3JqQkZCUE1xS1NDdVVQNVk1bV83NVY0QUJ6Y2ctVU5NWTE5NjlQWHY2VGRMS3VEUUdiTzh0a0xwNjhXdTF3U0JJdTc4ZmdUa1…
Eastman Chemical (EMN) Stock Looks Cheap But Cash Flow Doubts Linger - simplywall.st
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNRGtXVFB5VW5vN29mNHJWTmhKTjJ5VlRhUmJacVRfeWVmQmJpcWZMTTBTV203VjN2ZURTWHVMN1dqSUp1MV9FS0FnbTJFeXc4Qmp5LUpxc3BxeWlmbER0cWxRMV9rSi1Qc0JrTkVFa1NUVUpCODdJdDdZUUdHRXRVVnlVRFM0WThwV1pESX…
Should Value Investors Buy Eastman Chemical (EMN) Stock? - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNUXdPQ1RPaW5tYm1Yc0RFMWxsR0VZR2E4eV9RMTNZbTQ0bHE0ZjJfdmFtTUMzNG96SloxOWJIU19lZTVldm5qTV9jWWdNS0Z2bWdQQzRmV0RTOC1Pc2plVEJyOGppT1pkTWx4QjFJNFFqdWZOU3J2VEpQYVNMSGZ3OFgtRHFzV1g0X1JUeH…
Eastman Chemical Co (EMN) Stock Down 3.2% -- Now Undervalued? GF Score: 72/100 - gurufocus.com
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQdWlqYWdTb0dRR1hxM3MtRk8xTUZOcTN6OWZxMzNRVlJaU0E5ZzJuUDRuM1J4cVdRTVhWdzRsdC1WWUVfc1FxZy1ZcnlCRjZtMElBdHR3YldsY0hKQXc0Z3p3cXQxLXBmZGdhM2R5WUFlR1d0MVprZGZibmhseFk1MEh5VlhpSXBQTEF1YW…
Why Eastman Chemical (EMN) is a Top Value Stock for the Long-Term - Eastern Progress
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxOa2pkOFFGS0dPRzBOak5GME96dHVvdHJVYkFpRVpBdmdTLVRfVTItR3B6SnB3TjRQcWpFQTE1b2paVzB1Wi1NR1hUNHlnSVBIMWZzMTMwU05aLU40N2kwVk1EVlh1ZE9VclJ4OElYdkRnMEpVY1M0VC16cWdRaVZGT2xVVlpJSEcxRkctTl…
Eastman stockholders of record to receive $0.84 dividend Oct. 7 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxNR2FPUXJMTjY1cFBqSWxDU1Y4OEk0OEpjeVMxdHI5YU5lWmw1TlNfMTBzWlRTMm8xaE8tYURBWUdNelZvYWx6WjNxUUs2eDlDeHBhbkIyRUtfWVdTSHJxSDlXUzlrd3BNYTBVTDJsT2tYODRPVGt5MUlrSjVpUEpwck1n?oc=5" target=…
EMN — Frequently Asked Questions
What is the current share price of Eastman Chemical Company (EMN)?
As of 2026-09-19 21:16 PDT, Eastman Chemical Company (EMN) trades at $70.39 on NYSE. Its 52-week range is $54.37 to $79.49.
What is the market capitalisation of EMN?
Eastman Chemical Company (EMN) has a market capitalisation of $8.05B on NYSE.
What is the P/E ratio of EMN?
EMN trades at a trailing price-to-earnings (P/E) ratio of 18.33. The industry average P/E is 22.16. Its price-to-book (P/B) ratio is 1.28.
Does EMN pay a dividend?
Eastman Chemical Company (EMN) currently offers a dividend yield of 4.77%.
What is the return on equity (ROE) of EMN?
EMN has a return on equity (ROE) of 7.33%. Its return on capital employed (ROCE) is 12.55%.
Is EMN a good stock to buy?
This page provides a data-driven analysis of Eastman Chemical Company (EMN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.